Condition
Chronic HBV Infection clinical trials and research
As of November 12, 2026, Find a Trial lists 2 Chronic HBV Infection clinical trials that are recruiting, at sites in 2 countries (most in China (1), Switzerland (1)). By phase: Phase 1/2 (1), Phase 2 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 2Countries
All recruiting trials (2)
-
LW231 treatment for people with chronic hepatitis B
This trial tests whether LW231, given alone or with standard antiviral NUCs, is safe and can lower hepatitis B virus measures in adults with chronic HBV.
-
Methylene Blue treatment for chronic Hepatitis B infection
This study tests if Methylene Blue can help adults with chronic Hepatitis B lower their virus levels enough to stop taking antiviral medication.
Quick answers
How many Chronic HBV Infection clinical trials are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 2 countries. The most sites are in China (1 trial), Switzerland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1/2: 1, Phase 2: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.